Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA) in Germany at the start of July priced at 1,945,000 eu ...

SonicWall patches three SMA 100 vulnerabilities, including a potential zero-day, that could be chained to execute arbitrary code remotely. SonicWall on Wednesday announced patches for three ...

Audit uncovers financial manipulation at eFishery since 2018, allegedly involving illicit fund transfers to employees.